Azala

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY

Erakutsi beste bertsioak (1)

Characteristics and classification of different patterns of paroxysmal atrial fibrillation are presented. Main indications to restoration of sinus rhythm are discussed. The features of main medications used to terminate of atrial fibrillation are given. The choice of antiarrhythmic drug is considera...

Deskribapen osoa

Gorde:

Xehetasun bibliografikoak
Egile nagusia:	B. A. Tatarskii (Egilea)
Formatua:	Liburua
Argitaratua:	Столичная издательская компания, 2015-12-01T00:00:00Z.
Gaiak:	article
Sarrera elektronikoa:	Connect to this object online.
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY
nork: B. A. Tatarskii
Argitaratua: (2015)

Pharmacological cardioversion of atrial fibrillation paroxysm in elderly and senile patients at prehospital stage
nork: Andrei V. Syrov
Argitaratua: (2021)

Rivaroxaban in atrial fibrillation cardioversion: an update
nork: Lavalle C, et al.
Argitaratua: (2019)

Efficiency and safety of pharmacological cardioversion for atrial fibrillation
nork: Aleksei V. Tarasov
Argitaratua: (2021)

Electric cardioversion as therapeutic modality in patients with atrial fibrillation
nork: Raúl Joaquín Varela García
Argitaratua: (2018)

Paroxysmal atrial fibrillation in cryptogenic stroke
nork: Neha S Dangayach, et al.
Argitaratua: (2011)

Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation
nork: N. A. Novikova, et al.
Argitaratua: (2016)

Physical rehabilitation in idiopathic paroxysmal atrial fibrillation
nork: O. D. Lebedeva
Argitaratua: (2020)

Antithrombotic Therapy in Patients with Paroxysmal Atrial Fibrillation after Catheter Treatment
nork: O. R. Eshmatov, et al.
Argitaratua: (2023)

FEATURES OF THE CARDIOVERSION IN ATRIAL FLUTTER AND FIBRILLATION IN ERA OF NEW ANTICOAGULANTS: PRACTICAL CARDIOLOGIST VIEW
nork: S. A. Zenin, et al.
Argitaratua: (2015)

FEATURES OF THE CARDIOVERSION IN ATRIAL FLUTTER AND FIBRILLATION IN ERA OF NEW ANTICOAGULANTS: PRACTICAL CARDIOLOGIST VIEW
nork: S. A. Zenin, et al.
Argitaratua: (2015)

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety
nork: N. Yu. Mironov, et al.
Argitaratua: (2019)

THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE
nork: S. N. Tereshchenko, et al.
Argitaratua: (2016)

Tactics of Antiarrhythmic Therapy in Comorbid Elderly and Senile Patients with Paroxysmal and Recurrent Atrial Fibrillation
nork: M. H. Fedorova, et al.
Argitaratua: (2018)

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
nork: L. N. Chikhireva, et al.
Argitaratua: (2015)

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
nork: L. N. Chikhireva, et al.
Argitaratua: (2015)

Left Atrial Thrombosis before Catheter Ablation or Cardioversion in Patients with Non-valvular Atrial Fibrillation or Atrial Flutter: what Risk Score is Most Informative?
nork: I. A. Zaigraev, et al.
Argitaratua: (2023)

Changes in Arterial Wall Stiffness in Patients with Obesity and Paroxysmal Form of Atrial Fibrillation
nork: V. I. Podzolkov, et al.
Argitaratua: (2020)

Paroxysmal Atrial Fibrillation Induced by Ciprofloxacin: A Rare Adverse Effect
nork: Fatma Hammami, et al.
Argitaratua: (2020)

Effect of cryoballoon ablation parameters on recurrence in patients with paroxysmal atrial fibrillation
nork: Abdullah Orhan Demirtaş, et al.
Argitaratua: (2019)

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness
nork: N. Yu. Mironov, et al.
Argitaratua: (2018)

FEATURES OF DAILY ECG MONITORING IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION AND ACCOMPANYING OBESITY
nork: Yuriy Kovbasniuk
Argitaratua: (2015)

COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE
nork: L. E. Kuvshinova, et al.
Argitaratua: (2015)

COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE
nork: L. E. Kuvshinova, et al.
Argitaratua: (2015)

Successful ablation of paroxysmal atrial fibrillation originating in left atrial appendage with single shot cryoballoon technique
nork: Uğur Canpolat, et al.
Argitaratua: (2017)

Predictors of class IC antiarrhythmic drugs efficacy in patients with paroxysmal form of atrial fibrillation
nork: Manizha A. Khalikova, et al.
Argitaratua: (2023)

Serum galectin-3 level predicts early recurrence following successful direct-current cardioversion in persistent atrial fibrillation patients
nork: Kadri Murat Gürses, et al.
Argitaratua: (2019)

PHARMACOEPIDEMIOLOGICAL ANALYSIS OF THE TREATMENT OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION IN EVERY DAY CLINICAL PRACTICE
nork: I. V. Graifer, et al.
Argitaratua: (2016)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
nork: Yu. P. Skirdenko, et al.
Argitaratua: (2020)

Left Atrial Strain Helps Identifying the Cardioembolic Risk in Transient Ischemic Attacks Patients with Silent Paroxysmal Atrial Fibrillation
nork: Arnăutu SF, et al.
Argitaratua: (2022)

Effectiveness of Class IC Antiarrhythmics in Patients with Paroxysmal Form of Atrial Fibrillation in Absence of Structural Heart Disease
nork: D. A. Tsaregorodtsev, et al.
Argitaratua: (2023)

Association of plasma fibronectin level with left atrial electrical and structural remodelling in lone paroxysmal atrial fibrillation: a cross-sectional study
nork: Uğur Canpolat, et al.
Argitaratua: (2015)

QDOT MICRO versus THERMOCOOL SMARTTOUCH and THERMOCOOL SMARTTOUCH Surround Flow in radiofrequency ablation of paroxysmal atrial fibrillation
nork: Jose Osorio, et al.
Argitaratua: (2023)

ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT
nork: E. L. Dolgova, et al.
Argitaratua: (2015)

ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT
nork: E. L. Dolgova, et al.
Argitaratua: (2015)

Successful treatment of neonatal atrial flutter by synchronized cardioversion: case report and literature review
nork: Monika Wójtowicz-Marzec, et al.
Argitaratua: (2020)

Nutritional Insights: How Food Choices Affect Atrial Fibrillation
nork: Daniel Gondko, et al.
Argitaratua: (2024)

Propafenone-induced liver injury in an elderly patient with paroxysmal atrial fibrillation--a new case report and literature review
nork: Katarzyna Giedzicz, et al.
Argitaratua: (2023)

NEW APPROACHES TO INDIVIDUALIZED CHOICE OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION
nork: Ju. P. Skirdenko, et al.
Argitaratua: (2018)

Study of the Effect of Proton Pump Inhibitors on the Development of Hypomagnesemia in Patients with Paroxysmal Atrial Fibrillation on the Background of Autonomic Sinus Node Dysfunction
nork: Ya. G. Bozhko, et al.
Argitaratua: (2020)